Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00004889 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]